{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:15:37Z","timestamp":1791087337692,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1016\/j.cellimm.2003.09.001","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T14:27:33Z","timestamp":1067351253000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["On the role of APC-activation for in vitro versus in vivo T cell priming"],"prefix":"10.1016","volume":"225","author":[{"given":"Tazio","family":"Storni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2003.09.001_BIB1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0952-7915(98)80119-2","article-title":"Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells","volume":"10","author":"Zajac","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB3","doi-asserted-by":"crossref","first-page":"15840","DOI":"10.1073\/pnas.262669499","article-title":"T cells take aim at cancer","volume":"99","author":"Pardoll","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB4","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0952-7915(02)00363-1","article-title":"Balancing protective immunity and immunopathology","volume":"14","author":"Bachmann","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-1759(97)00089-6","article-title":"A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy","volume":"207","author":"Oehen","year":"1997","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1521-4141(200203)32:3<818::AID-IMMU818>3.0.CO;2-U","article-title":"Cross-presentation of virus-like particles by skin-derived CD8(\u2212) dendritic cells: a dispensable role for TAP","volume":"32","author":"Ruedl","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB9","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.4049\/jimmunol.168.6.2880","article-title":"Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles","volume":"168","author":"Storni","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB10","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/eji.1830270931","article-title":"CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants","volume":"27","author":"Lipford","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB12","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.187.7.1145","article-title":"DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen","volume":"187","author":"Sun","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4049\/jimmunol.160.3.1122","article-title":"Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds","volume":"160","author":"Macfarlane","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.156.2.558","article-title":"IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides","volume":"156","author":"Yi","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB16","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.167.7.3555","article-title":"Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells","volume":"167","author":"Takeshita","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2567.2000.00077.x","article-title":"Poly-guanosine motifs costimulate antigen-reactive CD8 T cells while bacterial CpG-DNA affect T-cell activation via antigen-presenting cell-derived cytokines","volume":"101","author":"Lipford","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/342559a0","article-title":"Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen","volume":"342","author":"Pircher","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB20","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0092-8674(94)90142-2","article-title":"Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy","volume":"77","author":"Crowther","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4049\/jimmunol.171.2.795","article-title":"Innate immunity together with duration of antigen persistence regulate effector T cell induction","volume":"171","author":"Storni","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/325192b0","article-title":"Antigen recognition. Class discrimination in the world of immunology","volume":"325","author":"Bevan","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB23","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.90.11.4942","article-title":"Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages","volume":"90","author":"Kovacsovics-Bankowski","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4049\/jimmunol.152.3.1110","article-title":"Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo","volume":"152","author":"Schirmbeck","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB25","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/eji.1830240944","article-title":"Induction of protective cytotoxic T cells with viral proteins","volume":"24","author":"Bachmann","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.7809629","article-title":"A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules","volume":"267","author":"Kovacsovics-Bankowski","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2003.09.001_BIB27","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.192.12.1685","article-title":"CD8(+) but not CD8(\u2212) dendritic cells cross-prime cytotoxic T cells in vivo","volume":"192","author":"den Haan","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB28","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.189.12.1875","article-title":"CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo","volume":"189","author":"Ruedl","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2003.09.001_BIB29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1074-7613(00)80308-8","article-title":"Duration of TCR stimulation determines costimulatory requirement of T cells","volume":"5","author":"Kundig","year":"1996","journal-title":"Immunity"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874903001965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874903001965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:37:33Z","timestamp":1757803053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874903001965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0008874903001965"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2003.09.001","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the role of APC-activation for in vitro versus in vivo T cell priming","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2003.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}